Invention Grant
- Patent Title: Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
-
Application No.: US15363103Application Date: 2016-11-29
-
Publication No.: US10202459B2Publication Date: 2019-02-12
- Inventor: Youngro Byun , In San Kim , Ahmed Al-Hilal Taslim , Sang-Yoon Kim , Ye Ji Jang
- Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION , UNIVERSITY OF ULSAN , KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY , PHAROSGEN
- Applicant Address: KR Seoul KR Ulsan KR Seoul KR Seoul
- Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION,UNIVERSITY OF ULSAN,KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY,PHAROSGEN
- Current Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION,UNIVERSITY OF ULSAN,KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY,PHAROSGEN
- Current Assignee Address: KR Seoul KR Ulsan KR Seoul KR Seoul
- Agency: Foley & Lardner LLP
- Priority: KR10-2015-0168485 20151130
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/28 ; A61K31/727 ; G01N33/574 ; G01N33/68 ; C07K14/705 ; C12N15/113 ; A61K47/54
Abstract:
Described herein are doppel-targeting molecules useful for inhibiting pathological angiogenesis and treating diseases and conditions associated with pathological angiogenesis, such as tumors, cancers, atherosclerosis, tuberculosis, asthma, pulmonary arterial hypertension (PAH), neoplasms and neoplasm-related conditions, and for detecting doppel expression in a subject. Related compositions and methods also are described.
Public/Granted literature
- US20170183416A1 METHODS OF INHIBITING PATHOLOGICAL ANGIOGENESIS WITH DOPPEL-TARGETING MOLECULES Public/Granted day:2017-06-29
Information query
